Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx PlexPrime SARS-CoV-2 Genotyping Lambda

SpeeDx has launched a SARS-CoV-2 variant genotyping assay designed to detect the Lambda variant. PlexPrime SARS-CoV-2 L452Q Lambda is a single-well mix designed to detect a spike mutation found in the C.37 variant of interest as well as an RdRp gene target of SARS-CoV-2. The reagent is the third product in the PlexPrime SARS-CoV-2 genotyping portfolio and can be used as a standalone reflex test or combined with PlexPrime SARS-CoV-2 Alpha/Beta/Gamma+ and PlexPrime P681R Delta. The assays are compatible with standard qPCR and liquid-handling instrumentation and can potentially reduce cost and manual steps in labs running high-volume sequence analysis, SpeeDx said.